Amgen
(NQ:
AMGN
)
312.50
-16.45 (-5.00%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
3
4
5
6
7
8
9
...
44
45
Next >
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical Readouts
Today 14:01 EDT
Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. Despite some underperformance, growth prospects remain strong, with...
Via
Benzinga
Why Amgen Stock Is Down Today Despite Solid Q2 Results
Today 13:11 EDT
Shares may have been likely to fall no matter what the company reported.
Via
The Motley Fool
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
Today 12:46 EDT
The U.S.
Via
Benzinga
Amgen's Options: A Look at What the Big Money is Thinking
August 02, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
July 30, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Amgen
July 26, 2024
Via
Benzinga
Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
Today 10:06 EDT
Amgen reported a 20% year-over-year increase in second-quarter sales, reaching $8.39 billion, surpassing the $8.33 billion consensus. Guidance for 2024 includes adjusted EPS of $19.10-$20.10 and...
Via
Benzinga
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Today 7:45 EDT
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AMGN Stock Earnings: Amgen Misses EPS, Beats Revenue for Q2 2024
August 06, 2024
AMGN stock results show that Amgen missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Market Whales and Their Recent Bets on AMGN Options
July 25, 2024
Via
Benzinga
Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report
August 06, 2024
Amgen stock fell late Tuesday after the biotech reported lighter-than-expected second-quarter profits, though sales beat.
Via
Investor's Business Daily
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
August 06, 2024
U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
August 06, 2024
Via
Benzinga
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
August 06, 2024
Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Good Stocks, Strategic Options, and a 4.5% Yield: There's a Lot to Like About This Unique ETF
August 05, 2024
Covered calls can generate income from an investment portfolio but can be complex. This Amplify ETF is a simple solution.
Via
The Motley Fool
Topics
ETFs
So Much For Expecting The Fed To Stick The Landing
August 04, 2024
Now is not the time to be fully invested.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Via
InvestorPlace
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
August 02, 2024
The innovative biotech is looking for its next blockbuster.
Via
The Motley Fool
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Via
InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
July 29, 2024
Passive income and ETFs represent two compelling market concepts. Why not bring the two together with dividend-paying ETFs?
Via
InvestorPlace
Topics
ETFs
3 Fabulous Growth Stocks to Buy and Hold Forever
July 24, 2024
The bull market in growth stocks is more than just chipmakers if investors will only widen their lens to see the opportunities available.
Via
InvestorPlace
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
3 Stocks That Are Melting Up. Is There Room to Run?
July 23, 2024
Buying stocks while they're melting up isn't without its fair share of risk. That said, these high-flyers look pretty enticing.
Via
InvestorPlace
10 Best Dividend Growth Stocks to Buy and Hold Forever
July 21, 2024
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Q2 Earnings Season Scorecard, Economic Outlook And Analyst Reports For Nvidia, Meta & Others
July 18, 2024
Today's Research Daily features a real-time update on the Q2 earnings season, the July Economic Outlook monthly, and new research reports on 16 major stocks, including NVIDIA, Meta, and Amgen as well...
Via
Talk Markets
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.